Cytokine-release syndrome: general risk-factor modification--preparation of high-risk patients for use of OKT3
Related Experiment Videos
1Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.
Transplantation Proceedings
|April 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Role of the serotonin transporter gene in the behavioral expression of autism.
Molecular psychiatry·2001
A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.
The American journal of psychiatry·2001
Mothers' functioning and children's symptoms 5 years after a SCUD missile attack.
The American journal of psychiatry·2001
3-Carboxamido analogues of morphine and naltrexone. synthesis and opioid receptor binding properties.
Bioorganic & medicinal chemistry letters·2001
Regional brain and ventricular volumes in Tourette syndrome.
Archives of general psychiatry·2001
Pre-Implantation Kidney Biopsy: Assessing Safety in Transplant Outcomes.
Transplantation proceedings·2026
Organ Donation-Reaching the Next Generation: To and Through High School.
Transplantation proceedings·2026
2,611 Liver Transplants: Indications and Survival Rates of a High-Volume Latin American Center.
Transplantation proceedings·2026
Machine Learning-Based Mortality Prediction for Mechanically Ventilated Liver Failure Patients: A Retrospective Study.
Transplantation proceedings·2026
Precision meets scale: DSB- and recombinase-free targeted insertion of large DNA fragments.
Biodesign research·2026
Research progress of gene correction for genetic diseases via in vivo prime editing.
Molecular genetics and genomics : MGG·2026
From particle engineering to direct compression: Tailoring compaction properties through microfluidic API-excipient co-processing.
International journal of pharmaceutics·2026